Bausch Health launches Clear + Brilliant in Canada

Executive Summary

• Bausch Health’s aesthetics subsidiary, Solta Medical, has launched the Clear + Brilliant Touch laser in Canada following Health Canada approval on May 20, 2025.
• The dual-wavelength fractional laser system expands Solta’s global product portfolio and addresses growing Canadian demand for non-invasive, customizable skin rejuvenation treatments.
• The device is indicated for dermatological procedures requiring soft tissue coagulation and skin resurfacing, offering minimal downtime and suitability for all skin types.

Key Details

• Regulatory Approval: Cleared by Health Canada on May 20, 2025.
• Product: Clear + Brilliant Touch Laser (dual-wavelength fractional laser system).
• Technology & Design: Features two distinct fractional laser hand pieces (1440 nm and 1927 nm) for seamless switching; suitable for all skin types, a wide range of ages, and year-round use at physician discretion.
• 1440 nm Hand Piece Indications: Treatment and improvement of wrinkles, dyschromia, pigmentation, skin texture, and pore size.
• 1927 nm Hand Piece Indications: Treatment and improvement of wrinkles, dyschromia, pigmentation, skin texture, enhancement of skin permeability, and pore size.
• Clinical & Market Background: Follows a successful United States launch in 2021; supported by more than 15 clinical studies; part of a platform that has defined the laser-treatment landscape globally since 2011.
• Strategic Impact: Expands Solta Medical’s global footprint and aligns with increasing consumer preference for effective, approachable, and non-invasive aesthetic procedures in Canada.

Notable Quotes

• Thomas J. Appio, CEO, Bausch Health: "The Solta business continues to expand its global presence through its diverse and well-established portfolio that supports the growing demand for high-quality aesthetics solutions... Canada is an important part of that growth, reflecting strong and sustained interest in the aesthetic market across the country."
• Jiny Kim, Senior Vice-President, Solta Medical: "Expanding the availability of the Clear + Brilliant touch system into Canada marks a significant step forward for Solta Medical and its commitment to global expansion of our innovative portfolio of products in skin health. This launch reinforces Solta's leadership in supporting both providers and patients with technology that delivers safe, effective and customizable results."